pain management

The hydrocodone questionAsking whether hydrocodone should be rescheduled is only the beginning.
FDA approves NSAID to address dose-related safety concernsFDA has approved diclofenac (Zorvolex, Iroko Pharmaceuticals) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the treatment of mild-to-moderate acute pain in adults.
OTC pain meds as good as Rxs after tonsillectomyOver-the-counter (OTC) pain relievers are just as effective as prescription pain medications for posttonsillectomy pain, say researchers from Henry Ford Hospital.
Pain control requires multidisciplinary approachPrevalence of chronic pain can add up to higher costs in mental-health and medical claims
New bipartisan bill seeks to reclassify hydrocodoneWill FDA classify hydrocodone as Schedule III, Schedule II, or somewhere in between?
FDA warns about codeine for childrens’ postop painFDA is adding its strongest warning to labels of codeine-containing products advising against their use for pain relief in children after surgery to remove tonsils or adenoids. The agency asks healthcare professionals to use alternate pain relievers instead.
Ethics and painA new bimonthly column from Ken Baker looks at ethical decision-making in pharmacy.